Effectiveness of Aspirin as Dementia Prophylaxis in Patients with Type 2 Diabetes
Mar 17, 2020
Editor: Steve Freed, R.PH., CDE
Author: Mia Flowers, PharmD. Candidate of Florida Agricultural & Mechanical University School of Pharmacy
Multiple risk factors put patients with T2DM at a high risk of developing dementia; is there evidence for effectiveness of aspirin as dementia prophylaxis?
Rates of dementia are steadily climbing, with estimates as high as 152 million by the year 2050. As a result, the total international cost for managing patients with dementia is also rising. With type 2 diabetes being a risk factor for dementia, especially vascular dementia, researchers have begun to work with diabetes patients to discover a means of preventing debilitating disease. This follow-up cohort study serves to compare and evaluate the efficacy of low-dose aspirin when used long-term as the prevention of dementia for both females and males.....
Agreement to pay later is required for access to the full text of this article. You will be charged only after your use reaches $5.00 (US) of site content. The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.